2020
Elbeddini A, Hooda N, Yang L. 2020. Role of Canadian pharmacists in managing drug shortage concerns amid the COVID-19 pandemic. Canad Pharmacists J 153(4)198-203; doi: 10.1177/1715163520929387 .
View Abstract
Topics: COVID-19 , Epidemiology
Fergie J, Suh M, Jiang X, Fryzek JP, Gonzales T. 2020. Respiratory syncytial virus and all-cause bronchiolitis hospitalizations among preterm infants using the Pediatric Health Information System (PHIS). J Infect Dis 225(7):1197-1204; doi: 10.1093/infdis/jiaa435 .
View Abstract
Topics: Epidemiology
Jensen IS , Hathway J, Cyr PL , Gauden D, Gardiner P. 2020. Cost–consequence analysis of 18 F-fluciclovine for the staging of recurrent prostate cancer. J Mark Access Health Pol 8(1):1749362; doi: 10.1080/20016689.2020.1749362 .
View Abstract
Topics: Cancer , Epidemiology , Health Economics and Outcomes Research (HEOR)
Hathway J, Miller-Wilson L, Jensen I , Ozbay B, Regan C, Jena A, et al. 2020. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives. J Med Econ 23(6):581-592; doi: 10.1080/13696998.2020.1730123 .
View Abstract
Topics: Cancer , Health Economics and Outcomes Research (HEOR)
Sacks NC , Everson K, Emden MR, Cyr PL , Wood DR, Raza S, Wood KA, Pokorney SD. 2020. Disparities in the management of newly diagnosed paroxysmal supraventricular tachycardia for women versus men in the United States. J Am Heart Assoc 9(19):e015910; 10.1161/JAHA.120.0159 .
View Abstract
Topics: Epidemiology
Sacks NC , Cyr PL , Preib MT, Everson K, Wood DR, Raza S, Pokorney SD. 2020. Healthcare resource use and expenditures in patients newly diagnosed with paroxysmal supraventricular tachycardia. Am J Cardiol 125(2):215–221; doi: 10.1016/j.amjcard.2019.10.015 .
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Su J, Bylsma LC , Jiang X , Morales Arias J, Jain N, Nordyke RJ . 2020. Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States. J Med Econ 23(8):902-907; doi: 10.1080/13696998.2020.1764006 .
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Busse LW, Nicholson G, Nordyke RJ , Lee C-H, Zeng F, Albertson TE. 2020. Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis. Intl J Tech Assess Health Care 36(2):145-151; doi: 10.1017/S0266462320000082 . PMID: 32114996.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Broome CM, Cunningham JM, Mullins M, Jiang X , Bylsma LC , Fryzek JP, Rosenthal A. 2020. Increased risk of thrombotic events in cold agglutinin disease: A 10-year retrospective analysis. Res Prac Thromb Haemostas 4(4):628-635; doi: 10.1002/rth2.12333 .
View Abstract
Topics: Epidemiology
Sattgast LH, Gallo S, Frankenfeld CL , Moshfegh AJ, Slavin M. 2020. Nutritional intake and bone health among adults with probable undiagnosed, untreated celiac disease: What We Eat in American and NHANES 2009–2014. J Am Coll Nutr 39:112–121.
View Abstract
A Division of